SEMA4A and neoplasm: Certain target genes (e.g., ERBB4, SEMA4A, GCNT2 and SOX4) play critical roles in shaping two pathways related to the malignant fate of AT2 cells, which are inseparable from tumor differentiation and migration, suggesting that these genes may be novel therapeutic targets for further studies (23).